|
| |
I W P C P S® 2 P
r o g r a m
Thursday
The "Second International Workshop
on Physical Characterization of Pharmaceutical Solids"
|
Thursday,
September 27, 2001 AM
|
|
Morphology/Surface
Characterization
Chair person for Thursday AM and PM:
Mike Van Oort
|
|
Subject
|
Speaker
|
Characterizing
Solids Using Thermal Microscopy and Vibrational Spectroscopy
|
John
Reffner
SensIR Technologies, USA |
| Advances
in the Characterisation of Pharmaceutical Materials using
IGC |
Daryl
Williams
Imperial College of Science, Technology and Medicine, UK |
| Characterization
of Surface Free Energies and Surface Chemistry of Solids |
Franck
Etzler
Boehringer Ingelheim, USA |
| Particle
Shape Analysis and its Effect on Powder Flow |
Mark
Bumiller
Malvern Instruments, USA |
| Effect
Of Crystal Habit Of Glycine On Wetting And Disintegration
Of Rapidly Disintegrating Tablet |
K.Terada
E. Yonemochi
Toho University,Japan. |
| Molecular
Modelling of Bulk Impurity Segregation and Impurity-mediated
Crystal Habit Modification of Organic Particulate Solids
|
G.
Clydesdale
Heriot-Watt University, UK
R B Hammond
K.J. Roberts
University of Leeds, UK. |
| Discussion
Round |
|
|
Thursday,
September 27, 2001 PM
|
|
Amorphous
Content - Determination And Characterization
|
|
Subject
|
Speaker
|
|
From
drug discovery to final formulation development: the importance
of solid-state characterization |
Magali
Sautel
Aventis Pharma, France |
| Amorphous
Content in Pharmaceutical Materials- Determination and Characterisation
|
Daryl
Williams
Imperial College of Science, Technology and Medicine, UK |
Small-
And Wide-Angle X-Ray Scattering For The Physical Characterization
Of Pharmaceutical Solids
|
Peter
Laggner
Austrian Academy of Sciences, and Hecus M.Braun-Graz X-Ray
Systems, Graz, Austria |
Characterization
And Quantitation of the Amorphous Phase in a Crystalline API
by Modulated Temperature Differential Scanning Calorimetry.
|
Daniel
Sherer
Charles Eckhart
Caesar Snodgrass-Pilla
Van Reif
Schering Plough Research Institute, USA |
| Determination
of Low amorphous content in pharmaceuticals by Thermally Stimulated
Current |
Marc
Galop
GlaxoSmithKline, Pharmaceutical Development, USA |
| Discussion
Round |
|
|
Thursday
Evening
Session
|
|
8
PM - 8.45 PM Regulatory Patents Issues on
|
|
Subject
|
Speaker
|
|
Strategies
for Patenting Pharmaceuticals
|
John
Palmer
Ladas & Parry, USA |
assa
reserves the right to change the faculty & agenda to accommodate
situations beyond its control.
---
|
|
|
